Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 3/20 | 0.52 |
| ▸ | MMP9 | P14780 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.46 |
| ▸ | THRA | P10827 | 3/20 | 0.45 |
| ▸ | THRB | P10828 | 3/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | CDC25A | P30304 | 7/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10052675 | 0.96 | MMP2 (0.56) | MMP2MMP9TDP1L3MBTL1 | |
| SCHEMBL7860409 | 0.86 | THRA (0.48) | MMP2MMP9THRATHRB | |
| SCHEMBL7854961 | 0.86 | THRA (0.48) | MMP2MMP9THRATHRB | |
| SCHEMBL7860406 | 0.86 | THRA (0.48) | MMP2MMP9THRATHRB | |
| SCHEMBL7860432 | 0.86 | THRA (0.48) | MMP2MMP9THRATHRB | |
| SCHEMBL7860408 | 0.83 | MMP2 (0.51) | MMP2MMP9CDC25A | |
| SCHEMBL7865130 | 0.83 | MMP2 (0.51) | MMP2MMP9CDC25A | |
| SCHEMBL7865124 | 0.83 | TSHR (0.58) | MMP2MMP9 | |
| SCHEMBL27522150 | 0.82 | MMP2 (0.46) | MMP2MMP9THRATHRB | |
| SCHEMBL10021381 | 0.81 | MMP2 (0.50) | MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0923529-B1 | SUBSTITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS | BAYER AG (US) | 2001-09-19 | — | — | EP | claimed |
| CN-1225620-A | Substituted 4-arylbutanoic acid derivatives as matrix metalloproteinase inhibitors | BAYER AG (US) | 1999-08-11 | — | — | CN | claimed |
| EP-0923529-A1 | SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS | Bayer Corporation (US) | 1999-06-23 | — | — | EP | claimed |
| WO-1997043237-A1 | SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS | BAYER CORPORATION (US) | 1997-11-20 | — | — | WO | claimed |
| EP-0923529-B1 | SUBSTITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS | BAYER AG (US) | 2001-09-19 | — | — | EP | disclosed |
| CN-1225620-A | Substituted 4-arylbutanoic acid derivatives as matrix metalloproteinase inhibitors | BAYER AG (US) | 1999-08-11 | — | — | CN | disclosed |
| EP-0923529-A1 | SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS | Bayer Corporation (US) | 1999-06-23 | — | — | EP | disclosed |
| US-5863915-A | ENZYME INHIBITORS FOR BONES AND JOINTS | BAYER CORPORATION (US) | 1999-01-26 | — | — | US | disclosed |
| WO-1997043237-A1 | SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS | BAYER CORPORATION (US) | 1997-11-20 | — | — | WO | disclosed |